Question

The New Animal Drug Application for AquAdvantage was finally approved by the FDA in 2016 with several containment safeguards implemented. What is not one of the containment safeguards in relation to AquAdvantage?

-Biological containment by releasing both male and female transgenic fishes
-"GURT can be accomplished by releasing only sterile, triploid fish"
-Physical containment by growing Aquadvantage only in land-based facilities that are far from the ocean
-Geographical containment by growing Aquadvantage outside of the US only
-Genetic use restriction technologies (GURT) by releasing only female transgenic fish

Answer 1

AquAdvantage does not implement physical containment by growing in land-based facilities far from the ocean.

Step-by-step explanation:

The containment safeguard that is not related to AquAdvantage is Physical containment by growing AquAdvantage only in land-based facilities that are far from the ocean.

The other containment safeguards include biological containment by releasing both male and female transgenic fishes, genetic use restriction technologies (GURT) by releasing only female transgenic fish, and geographical containment by growing AquAdvantage outside of the US only.